![](/img/cover-not-exists.png)
ASXL1 and BIM germ line variants predict response and identify CML patients with the greatest risk of imatinib failure
Marum, Justine E., Yeung, David T., Purins, Leanne, Reynolds, John, Parker, Wendy T., Stangl, Doris, Wang, Paul P. S., Price, David J., Tuke, Jonathan, Schreiber, Andreas W., Scott, Hamish S., Hughes,Volume:
1
Journal:
Blood Advances
DOI:
10.1182/bloodadvances.2017006825
Date:
August, 2017
File:
PDF, 1.25 MB
2017